The Latest Analyst Ratings for Encompass Health
Portfolio Pulse from Benzinga Insights
In the last quarter, Encompass Health (NYSE:EHC) received 3 bullish, 4 somewhat bullish, and 2 indifferent ratings from analysts. The company has an average 12-month price target of $78.78, with a high of $85.00 and a low of $70.00. This average price target has increased by 10.96% over the past month.
September 28, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Encompass Health received mostly positive ratings from analysts in the last quarter. The average 12-month price target has increased by 10.96% over the past month.
The positive ratings and the increase in the average 12-month price target indicate a positive outlook for Encompass Health. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100